SEARCH

SEARCH BY CITATION

REFERENCES

  • Ambrosini G, Nath AK, Sierra-Honigmann MR & Flores-Riveros J (2002). Transcriptional activation of the human leptin gene in response to hypoxia. Involvement of hypoxia-inducible factor 1. J Biol Chem 277, 3460134609.
  • Arnalich F, Hernanz A, Lopez-Maderuelo D, Pena JM, Camacho J, Madero R, Vazquez JJ & Montiel C (2000). Enhanced acute-phase response and oxidative stress in older adults with type II diabetes. Horm Metab Res 32, 407412.
  • Barzilai N, Wang J, Massilon D, Vuguin P, Hawkins M & Rossetti L (1997). Leptin selectively decreases visceral adiposity and enhances insulin action. J Clin Invest 100, 31053110.
  • Braun B, Rock PB, Zamudio S, Wolfel GE, Mazzeo RS, Muza SR, Fulco CS, Moore LG & Butterfield GE (2001). Women at altitude: short-term exposure to hypoxia and or alpha(1)-adrenergic blockade reduces insulin sensitivity. J Appl Physiol 91, 623631.
  • Breslow MJ, Min-Lee K, Brown DR, Chacko VP, Palmer D & Berkowitz DE (1999). Effect of leptin deficiency on metabolic rate in ob/ob mice. Am J Physiol 276, E443E449.
  • Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ & Kahn CR (1998). A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2, 559569.
  • Calderon R, Llerena LA, Munive L & Kruger F (1966). Intravenous glucose tolerance test in pregnancy in women living in chronic hypoxia. Diabetes 15, 130132.
  • Ceddia RB, Koistinen HA, Zierath JR & Sweeney G (2002). Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J 16, 11631176.
  • Chen YW, Zhao P, Borup R & Hoffman EP (2000). Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol 151, 13211336.
  • Chin K, Shimizu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y, Mishima M, Nakao K & Ohi M (1999). Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnoea syndrome following nasal continuous positive airway pressure therapy. Circulation 100, 706712.
  • Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ & Bauer TL (1996). Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334, 292295.
  • Davidson MB, & Aoki VS (1970). Fasting glucose homeostasis in rats after chronic exposure to hypoxia. Am J Physiol 219, 378383.
  • Farooqi IS, Keogh JM, Kamath S, Jones S, Gibson WT, Trussell R, Jebb SA, Lip GY & O'Rahilly S (2001). Partial leptin deficiency and human adiposity. Nature 414, 3435.
  • Fletcher EC, Lesske J, Qian W, Miller CC & Unger T (1992). Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 19, 555561.
  • Friedman JM, (1998). Leptin, leptin receptors, and the control of body weight. Nutr Rev 56, s38s46.
  • Gastaut H, Tassinari CA & Duron B (1966). Polygraphic study of the episodic diurnal and nocturnal (hypnic and respiratory) manifestations of the Pickwick syndrome. Brain Research 1, 167186.
  • Grosfeld A, Zilberfarb V, Turban S, Andre J, Guerre-Millo M & Issad T (2002). Hypoxia increases leptin expression in human PAZ6 adipose cells. Diabetologia 45, 527530.
  • Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK & Friedman JM (1995). Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269, 543546.
  • Hon WC, Wilson MI, Harlos K, Claridge TD, Schofield CJ, Pugh CW, Maxwell PH, Ratcliffe PJ, Stuart DI & Jones EY (2002). Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature 417, 975978.
  • Ip MS, Lam B, Ng MM, Lam WK, Tsang KW & Lam KS (2002). Obstructive sleep apnoea is independently associated with insulin resistance. Am J Respir Crit Care Med 165, 670676.
  • Ip MS, Lam KS, Ho C, Tsang KW & Lam W (2000). Serum leptin and vascular risk factors in obstructive sleep apnoea. Chest 118, 580586.
  • Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawler AM, Yu AY & Semenza GL (1998). Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12, 149162.
  • James DJ, Cairns F, Salt IP, Murphy GJ, Dominiczak AF, Connell JM & Gould GW (2001). Skeletal muscle of stroke-prone spontaneously hypertensive rats exhibits reduced insulin-stimulated glucose transport and elevated levels of caveolin and flotillin. Diabetes 50, 21482156.
  • Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, Yuan M, Li ZW, Karin M, Perret P, Shoelson SE & Shulman GI (2001). Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108, 437446.
  • Kim YB, Uotani S, Pierroz DD, Flier JS & Kahn BB (2000). In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology 141, 23282339.
  • Kulkarni RN, Wang ZL, Wang RM, Hurley JD, Smith DM, Ghatei MA, Withers DJ, Gardiner JV, Bailey CJ & Bloom SR (1997). Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest 100, 27292736.
  • Lambert PD, Anderson KD, Sleeman MW, Wong V, Tan J, Hijarunguru A, Corcoran TL, Murray JD, Thabet KE, Yancopoulos GD & Wiegand SJ (2001). Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity. Proc Natl Acad Sci U S A 98, 46524657.
  • Larsen JJ, Hansen JM, Olsen NV, Galbo H & Dela F (1997). The effect of altitude hypoxia on glucose homeostasis in men. J Physiol 504, 241249.
  • Li B, Nolte LA, Ju JS, Han DH, Coleman T, Holloszy JO & Semenkovich CF (2000). Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice. Nat Med 6, 11151120.
  • Liang KY, & Zeger SL (1986). Longitudinal data analysis using generalized linear models. Biometrika 73, 1322.
  • Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R & Ranganathan S (1995). Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1, 11551161.
  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412419.
  • Menahan LA, (1983). Age-related changes in lipid and carbohydrate metabolism of the genetically obese mouse. Metabolism 32, 172178.
  • Misbin RI, Almira EC & Cleman MW (1981). Insulin degradation in serum of a patient with apparent insulin resistance. J Clin Endocrinol Metab 52, 177180.
  • Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB & O'Rahilly S (1997). Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387, 903908.
  • Mooe T, Franklin KA, Holmstrom K, Rabben T & Wiklund U (2001). Sleep-disordered breathing and coronary artery disease. Long-term prognosis. Am J Respir Crit Care Med 164, 19101913.
  • Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD & Pickering TG (2000). Association of sleep-disordered breathing, sleep apnoea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283, 18291836.
  • Peppard PE, Young T, Palta M & Skatrud J (2000). Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342, 13781384.
  • Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR & Smith PL (2002). Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165, 677682.
  • Ravussin E, Pratley RE, Maffei M, Wang H, Friedman JM, Bennett PH & Bogardus C (1997). Relatively low plasma leptin concentrations precede weight gain in Pima Indians. Nat Med 3, 238240.
  • Saltiel AR, & Kahn CR (2001). Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799806.
  • Schwartz MW, Peskind E, Raskind M, Boyko EJ & Porte DJ (1996). Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 2, 589593.
  • Seufert J, Kieffer TJ & Habener JF (1999). Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice. Proc Natl Acad Sci U S A 96, 674679.
  • Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier NF, O'Connor GT, Boland LL, Schwartz JE & Samet JM (2001). Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163, 1925.
  • Sivitz WI, Walsh SA, Morgan DA, Thomas MJ & Haynes WG (1997). Effects of leptin on insulin sensitivity in normal rats. Endocrinology 138, 33953401.
  • Steppan C, Bailey S, Bhat S, Brown E & Banerjee R (2001). The hormone resistin links obesity to diabetes. Nature 409, 307312.
  • Strohl KP, Novak RD, Singer W, Cahan C, Boehm KD, Denko CW & Hoffstem VS (1994). Insulin levels, blood pressure and sleep apnoea. Sleep 17, 614618.
  • Tagaito Y, Polotsky VY, Campen MJ, Wilson JA, Balbir A, Smith PL, Schwartz AR & O'Donnell CP (2001). A model of sleep-disordered breathing in the C57BL/6J mouse. J Appl Physiol 91, 27582766.
  • Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S et al. (1994). Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372, 182186.
  • Tankersley C, Kleeberger S, Russ B, Schwartz A & Smith P (1996). Modified control of breathing in genetically obese (ob/ob). mice. J Appl Physiol 81, 716723.
  • Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A & Chrousos GP (2000). Sleep apnoea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85, 11511158.
  • Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S & White MF (1998). Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900904.
  • Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P & Kadowaki T (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7, 941946.
  • Zeger SL, & Liang KY (1986). Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42, 121130.
  • Zhang Y, Proenca R, Maffei M, Barone M, Leopold L & Friedman JM (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425432.
  • Zisman A, Peroni OD, Abel ED, Michael MD, Mauvais-Jarvis F, Lowell BB, Wojtaszewski JF, Hirshman MF, Virkamaki A, Goodyear LJ, Kahn CR & Kahn BB (2000). Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 6, 924928.